期刊文献+

甲氨蝶呤治疗类风湿关节炎的剂量与途径 被引量:5

原文传递
导出
摘要 类风湿关节炎(RA)是一种病因未明的慢性炎性疾病,临床表现以关节侵蚀破坏为主,最终可引起患者生活质量、工作能力降低,精神心理障碍及过早死亡。因此,类风湿关节炎的治疗目标不仅是消除症状,还应阻止关节破坏与病情进展,即改善病情。因此,如何进行药物剂量个体化与给药途径选择成为风湿病学家们不断探索的话题。本研究对甲氨蝶呤剂量个体化及选择合适给药途径进行文献综述。
作者 杨璐 刘升云
出处 《中国实用医刊》 2013年第11期116-117,共2页 Chinese Journal of Practical Medicine
  • 相关文献

参考文献9

  • 1Felson DT, Smolen JS, Wells G,et al. American college of rheumatol-ogy/ european league against rheumatism provisional definition of re-mission in rheumatoid arthritis for clinical trials[ J]. Ann Rheum Dis,2011,70(3):404^13.
  • 2Swierkot J,SzecHinski J. Methotrexate in rheumatoid arthriti [ J ].PHarmacol Rep ,2006,58(4) :473-492.
  • 3Tian H,Cronstein BN. Understandingthe Mechanisms of action of metho-trexate :implications for the treatment of rheumatoid arthritis [ J ]. BullNYU Hosp Jt Dis,2007,65(3) : 168-173.
  • 4Riksen NP,Barrera P, Broek PH. Methotrexate modulates the kineticsof adenosine in humans in vivo[ J]. Ann Rheum Dis,2006.65 (4 ):465-470.
  • 5Albrecht K, Muller-Ladner U. Side effects and management of sideeffects of methotrexate in rheumatoid arthritis[ J]. Clin Exp Rheuma-tol,2010,28 (Suppl 61) :S95-S101.
  • 6Seto Y,Tanaka E,Inoue E,et al. Studies of the effcacy and safety ofmethotrexate at dosages over 8 mg/week using the IORRA cohort data-base [J]. Mod Rheumatol,2007 ,17(2) :98-105.
  • 7Lambert CM, Sandhu S, Lochhead A, et al. Doseescalation of paren-teral methotrexate in active rheumatoid arthritis that has been unre-sponsive to conventional doses of methotrexate : a randomized,con-trolled trial[ J]. Arthritis Rheum, 2004,50(2) :364-371.
  • 8Verstappen SM, Jacobs JW, Veen MJ, et al. Intensive treatment withmethotrexate in early rheumatoid arthritis : aiming for remission. Com-puter Assisted Management in Early Rheumatoid Arthritis ( CAMERA,an open-label strategy trial) [ J ]. Ann Rheum Dis,2007,66 ( 8 ):1443-1449.
  • 9Braun J,Kaestner P, Flaxenberg P, et al. Comparison of the clinicalefficacy and safety of subcutaneous versus oral administration of meth-otrexate in patients with active rheumatoid arthritis [ J ] . ArthritisRheum, 2008,58(10) :73-81.

同被引文献51

  • 1孙淑银.羟氯喹联合甲氨蝶呤治疗类风湿性关节炎的疗效[J].求医问药(下半月),2013(9):286-287. 被引量:3
  • 2杨卫平.甲氨蝶呤联合针灸治疗类风湿关节炎的临床观察[J].现代中西医结合杂志,2006,15(3):301-302. 被引量:3
  • 3王承德,沈丕安,胡荫奇.实用中医风湿病学[M].2版.北京:人民卫生出版社,2009:531,532.
  • 4中华医学会风湿病学分会,类风湿关节炎诊断与治疗指南[J].中华风湿病学杂志,2010,14(4):267.
  • 5Kremer JM, Genovese MC, Grant W, et al. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methortexate [ J ]. Ann Intern Med,2002,137:726.
  • 6夏光涛,户中丹,张立民,等.阿达木单抗治疗风湿病的疗效评价[J].医药专论,2011,32(8):453.
  • 7Hoff M, Kvien TK, Kalvesten J, et al. Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response : subanalysis of the PREMIER study[ J. BMC Musculoskeletal Disorders, 2011, 12 (1) :54-59.
  • 8Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid ar- thritis[ J]. Arthritis Rheum, 1988,31 ( 3 ) :315.
  • 9Charles P, Elliott MJ, Davis D, et al. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-aIpha therapy in rheumatoid arthritis[ J]. J Immunol, 1999,163 ( 3 ) : 1521-1528.
  • 10Aletaha D,Neogi T,Silman A,et al. 2010 Rheumatoid Arthritis Classi-fication Criteria[J]. Arthritis Rheumatism,2010,62( 9) : 2569 - 2581.

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部